Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-244,355
Closed -$6.12M 369
2019
Q4
$6.12M Buy
244,355
+6,424
+3% +$145K 0.07% 225
2019
Q3
$5.04M Buy
237,931
+128,516
+117% +$2.74M 0.06% 234
2019
Q2
$2.43M Sell
109,415
-3,302
-3% -$79.8K 0.03% 265
2019
Q1
$3M Buy
112,717
+10,255
+10% +$291K 0.04% 258
2018
Q4
$2.63M Sell
102,462
-7,724
-7% -$267K 0.04% 257
2018
Q3
$4.75M Sell
110,186
-1,061
-1% -$47.5K 0.07% 227
2018
Q2
$4.83M Buy
111,247
+14,265
+15% +$577K 0.07% 226
2018
Q1
$3.57M Buy
96,982
+40,034
+70% +$1.47M 0.05% 238
2017
Q4
$2.05M Sell
56,948
-3,349
-6% -$113K 0.03% 272
2017
Q3
$2.15M Buy
+60,297
New +$1.97M 0.03% 275

Other funds holding NOV

Boston Trust Walden's NOV Position: Q1 2020 in Review

Boston Trust Walden sold out of NOV (NOV) in Q1 2020, closing a stake of 244,355 shares — an estimated $6.12M sold.

Boston Trust Walden first reported a position in NOV in Q3 2017 and held it in 10 quarters. The position peaked at $6.12M in Q4 2019. 441 funds tracked by Wall St. Rank hold NOV as of Q1 2020.

  • Boston Trust Walden reported no remaining NOV position as of Q1 2020 after selling out during the quarter.
  • Boston Trust Walden sold 244,355 NOV shares in Q1 2020, an estimated $6.12M.
  • Boston Trust Walden first reported a position in NOV in Q3 2017 and held it in 10 quarters.
  • Boston Trust Walden's NOV position peaked at $6.12M in Q4 2019.
  • 441 funds tracked by Wall St. Rank held NOV as of Q1 2020.

Based on Boston Trust Walden's 13F filing for Q1 2020, filed 21 Apr 2020.